MIL108 - Beijing Mabworks Biotech, Biocytogen
BCG005 - Biocytogen
BCG008 - Biocytogen
BCG003 - Biocytogen, Guilin SanJin Group
https://www.businesswire.com/news/home/20221017005654/en/Biocytogen-to-Present-Progress-of-Preclinical-and-Clinical-Assets-at-BIO-EUROPE-2022
 
Oct 17, 2022